Literature DB >> 594643

Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function.

H Ring-Larsen.   

Abstract

The RBF was measured by means of the 133Xe washout method in seventy patients with cirrhosis. The average RBF in controls was 3.72 ml/g-min compared with 2.34 in the patients without ascites, 1.82 in the decompensated patients, 1.47 in the patients with azotaemia and 1.13 in the patients with additional oliguria. The RBF was not significantly correlated to changes in the systemic or portal haemodynamics. Likewise it was not correlated to any biochemical test of liver function except the serum albumin concentration (P less than 0.01). From the present results it can be concluded that a reduction in RBF in cirrhosis frequently is present before sodium and water retention is clinically evident and before laboratory proof of impairment of renal function, and that a subnormal serum albumin concentration may be a factor among several leading to renal hypoperfusion in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 594643     DOI: 10.3109/00365517709100657

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  15 in total

Review 1.  Pathogenesis of ascites and hepatorenal syndrome.

Authors:  S P Wilkinson; K P Moore; V Arroyo
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  The hepatorenal syndrome revisited.

Authors:  S P Wilkinson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

3.  Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.

Authors:  J H Henriksen; H Ring-Larsen; I L Kanstrup; N J Christensen
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

4.  The kidney and liver diseases.

Authors:  S P Wilkinson
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

5.  Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.

Authors:  Juan Carlos Q Velez; Paul J Nietert
Journal:  Am J Kidney Dis       Date:  2011-09-29       Impact factor: 8.860

6.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 7.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

8.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

9.  Endothelin and vascular function in liver disease.

Authors:  K Moore
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.

Authors:  H Ring-Larsen; U Palazzo
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.